Prolonged Tp-e interval and Tp-e/Qt correlates well with modified Rodnan skin severity score in patients with systemic sclerosis

Cardiology Journal

Volumn 23, Issue 3, 2016, Pages 242-249

  Okutucu, Sercan ^a   Karakulak, Ugur Nadir ^b   Aksoy, Hakan ^a   Sabanoglu, Cengiz ^c   Hekimsoy, Vedat ^d   Sahiner, Levent ^d   Kaya, Ergun Baris ^d   Akdogan, Ali ^d   Kabakci, Giray ^d   Aytemir, Kudret ^d   Tokgozoglu, Lale ^d   Oto, Ali ^a  

^a ANKARA NUMUNE HOSPITAL   (Turkey)

^b Occupational Diseases Hospital   (Turkey)

^c Kirikkale Highly Specialized Hospital   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Systemic sclerosis; Tp e interval; Tp e qt ratio

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MODIFIED RODNAN SKIN SEVERITY SCORE; QT INTERVAL; QT PROLONGATION; SCORING SYSTEM; SYSTEMIC SCLEROSIS; T-PEAK TO T-END; TRANSTHORACIC ECHOCARDIOGRAPHY; ARRHYTHMIAS, CARDIAC; COMPLICATION; ECHOCARDIOGRAPHY; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY; SCLERODERMA, SYSTEMIC;

ARRHYTHMIAS, CARDIAC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 84978045338     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.a2016.0021     Document Type: Article

References (38)

1. Jimenez SA, Derk CT. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Internal Med, 2004; 140: 37-50.
2. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol, 1988; 15: 202-205.
3. Champion HC. The heart in scleroderma. Rheumatic Diseases Clinics of North America, 2008; 34: 181-190; viii.
4. Morelli S, Sgreccia A, Ferrante L et al. Relationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma). Int J Cardiol, 1996; 57: 151-160.
5. Steen V. The heart in systemic sclerosis. Current Rheumatology Reports, 2004; 6: 137-140.
6. Antzelevitch C. Heterogeneity and cardiac arrhythmias: An overview. Heart Rhythm, 2007; 4: 964-972.
7. Yan GX, Martin J. Electrocardiographic T wave: A symbol of transmural dispersion of repolarization in the ventricles. J Cardiovasc Electrophysiol, 2003; 14: 639-640.
8. Antzelevitch C, Sicouri S, Di Diego JM et al. Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm, 2007; 4: 1114-1116; author reply 1116-1119.
9. Panikkath R, Reinier K, Uy-Evanado A et al. Prolonged Tpeak-to-tend interval on the resting ECG is associated with increased risk of sudden cardiac death. Circ Arrhythm Electrophysiol, 2011; 4: 441-447.
10. Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E. The long QT syndrome: A prospective international study. Circulation, 1985; 71: 17-21.
11. Bjerregaard P, Gussak I. Short QT syndrome. Ann Noninvasive Electrocardiol, 2005; 10: 436-440.
12. Gupta P, Patel C, Patel H et al. T(p-e)/QT ratio as an index of ar-rhythmogenesis. J Electrocardiol, 2008; 41: 567-574.
13. Zhao X, Xie Z, Chu Y et al. Association between Tp-e/QT ratio and prognosis in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Clin Cardiol, 2012; 35: 559-564.
14. Ciftci O, Onat AM, Yavuz B et al. Cardiac repolarization abnormalities and increased sympathetic activity in scleroderma. J National Med Association, 2007; 99: 232-237.
15. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheumatism, 1980; 23: 581-590.
16. Amanzi L, Braschi F, Fiori G et al. Digital ulcers in scleroderma: Staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford), 2010; 49: 1374-1382.
17. Maverakis E, Patel F, Kronenberg DG et al. International consensus criteria for the diagnosis of Raynaud’s phenomenon. J Autoimmunity, 2014; 48-49: 60-65.
18. Czirjak L, Foeldvari I, Muller-Ladner U. Skin involvement in systemic sclerosis. Rheumatology (Oxford), 2008; 47 suppl. 5: v44-v45.
19. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr, 2005; 18: 1440-1463.
20. Lang RM, Badano LP, Mor-Avi V et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imag, 2015; 16: 233-270.
21. Funck-Brentano C, Jaillon P. Rate-corrected QT interval: Techniques and limitations. Am J Cardiol, 1993; 72: 17B-22B.
22. Castro Hevia J, Antzelevitch C, Tornes Barzaga F et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol, 2006; 47: 1828-1834.
23. Shimizu M, Ino H, Okeie K et al. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol, 2002; 25: 335-339.
24. Yamaguchi M, Shimizu M, Ino H et al. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: A new index for arrhythmogenicity. Clinical Science, 2003; 105: 671-676.
25. Wranicz JK, Strzondala M, Zielinska M et al. [Evaluation of early cardiovascular involvement in patients with systemic sclerosis]. Przegl Lek, 2000; 57: 389-392.
26. Bienias P, Ciurzynski M, Glinska-Wielochowska M et al. Heart rate turbulence impairment and ventricular arrhythmias in patients with systemic sclerosis. Pacing Clin Electrophysiol, 2010; 33: 920-928.
27. Paradiso M, Di Franco M, Musca A et al. Ventricular late potentials in systemic sclerosis: Relationship with skin involvement. J Rheumatol, 2002; 29: 1388-1392.
28. Sgreccia A, Morelli S, Ferrante L et al. QT interval and QT dispersion in systemic sclerosis (scleroderma). J Internal Med, 1998; 243: 127-132.
29. Follansbee WP, Curtiss EI, Medsger TA, Jr., Owens GR, Steen V., Rodnan GP. Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma. Am J Med, 1984; 77: 489-496.
30. Deswal A, Follansbee WP. Cardiac involvement in scleroderma. Rheumatic diseases Clinics of North America, 1996; 22: 841-860.
31. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation, 1976; 53: 483-490.
32. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res, 1991; 68: 1729-1741.
33. Vaseghi M, Yamakawa K, Sinha A et al. Modulation of regional dispersion of repolarization and T-peak to T-end interval by the right and left stellate ganglia. Am J Physiol Heart Circ Physiol, 2013; 305: H1020-H1030.
34. Tanabe Y, Inagaki M, Kurita T et al. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol, 2001; 37: 911-919.
35. Karakulak UN, Okutucu S, Sahiner L et al. Assessment of cardiac autonomic nervous system involvement in systemic sclerosis via exercise heart rate recovery. Med Princ Pract 2015; 24: 17-22.
36. Mountantonakis S, Deo R. Biomarkers in atrial fibrillation, ventricular arrhythmias, and sudden cardiac death. Cardiovascular Therapeutics, 2012; 30: e74-e80.
37. Acar GR, Akkoyun M, Nacar AB et al. Evaluation of Tp-e interval and Tp-e/QT ratio in patients with rheumatoid arthritis. Turk Kardiyol Dern Ars, 2014; 42: 29-34.
38. Acar G, Yorgun H, Inci MF et al. Evaluation of Tp-e interval and Tp-e/QT ratio in patients with ankylosing spondylitis. Modern Rheumatology/the Japan Rheumatism Association 2013.